… We present a patient showing the difficulties of evaluating a patient with a pancreatic mass
(courtesy of … They may present with a pancreatic mass as in our patient. The symptoms of …

… not the information obtained has the potential to change patient management (Table 3). In …
patient consent must be obtained before the procedure. If the information will not affect patient …

… PET detected peritoneal metastasis in 25% of patients, missing poorly localized
microscopic spread. For selected patients who have indeterminate pancreatic masses but no …

… Forty patients with clinical and ultrasonographic evidence of pancreatic masses underwent
MSCT and MRI. The majority of patients (31/40, 78%) had proven malignant pancreatic …

… of a patient presenting with a solid pancreatic mass requires … presentations of a solid
pancreatic mass, which can be both … , with special attention to pancreatic adenocarcinoma and its …

… The aims of this study were to compare the diagnostic yield of EUS-FNA in the evaluation
of pancreatic-mass lesions in patients with and without CP in a North American population. …

… of the strain histogram in the patients with pancreatic masses and to determine the cut-off
value between pancreatic malignancy and focal pancreatitis using software integrated into the …

… lesion is a critical first step toward developing an appropriate treatment plan for patients
with a benign or malignant pancreatic mass. Technological advances in cross-sectional and …

… of this new device in patients with solid pancreatic masses. … EUS-FNA of pancreatic masses
is safe,5., 6. has an overall … in a patient with a pancreatic mass does not rule out pancreatic …

… EUS-FNA of solid pancreatic masses infrequently leads to major … patients before EUS-FNA
of solid pancreatic masses. … to counsel patients before EUS-FNA of solid pancreatic masses. …